SARS-CoV-2 vaccination in inflammatory bowel disease (IBD) patients - does treatment for IBD negatively affect SARS-CoV-2 antibodies? A single-centre, prospective study.

MLA

Karłowicz, Katarzyna, et al. “SARS-CoV-2 Vaccination in Inflammatory Bowel Disease (IBD) Patients - Does Treatment for IBD Negatively Affect SARS-CoV-2 Antibodies? A Single-Centre, Prospective Study.” Przeglad Gastroenterologiczny, vol. 19, no. 2, 2024, pp. 198–205. EBSCOhost, https://doi.org/10.5114/pg.2023.130126.

APA

Karłowicz, K., Lewandowski, K., Tulewicz-Marti, E., Maciejewska, K., Tworek, A., Stępień-Wrochna, B., Głuszek-Osuch, M., Łodyga, M., & Rydzewska, G. (2024). SARS-CoV-2 vaccination in inflammatory bowel disease (IBD) patients - does treatment for IBD negatively affect SARS-CoV-2 antibodies? A single-centre, prospective study. Przeglad Gastroenterologiczny, 19(2), 198–205. https://doi.org/10.5114/pg.2023.130126

Chicago

Karłowicz, Katarzyna, Konrad Lewandowski, Edyta Tulewicz-Marti, Katarzyna Maciejewska, Adam Tworek, Beata Stępień-Wrochna, Martyna Głuszek-Osuch, Michał Łodyga, and Grażyna Rydzewska. 2024. “SARS-CoV-2 Vaccination in Inflammatory Bowel Disease (IBD) Patients - Does Treatment for IBD Negatively Affect SARS-CoV-2 Antibodies? A Single-Centre, Prospective Study.” Przeglad Gastroenterologiczny 19 (2): 198–205. doi:10.5114/pg.2023.130126.